Draft CoRAP update with new substances for evaluation in 2015-2017 published

ECHA has prepared a proposal to update the Community rolling action plan (CoRAP). The draft plan contains 134 substances that are proposed to be evaluated in 2015-2017 by the Member States under the REACH Regulation.


Helsinki, 30 October 2014 - The draft update list contains 65 newly selected substances and 69 substances from the plan adopted and published on 26 March 2014. These substances are allocated for evaluation during 2015, 2016 and 2017.

ECHA publishes the draft plan including the non-confidential substance names, CAS and EC-numbers, the tentative year of evaluation, and the contact details of the proposed evaluating Member State as well as a brief indication of the initial area of concern.

The draft plan has been prepared in close cooperation with the Member States, taking into account the agreed risk-based criteria for the selection of substances. The Member States have also proposed substances based on national priorities.

In the next step, the ECHA Member State Committee starts its discussions this week and will prepare an opinion on the draft plan in February 2015. ECHA will then adopt the final CoRAP update for 2015-2017 on the basis of the Committee's opinion. The CoRAP process does not include a public consultation. However, by publishing this draft list of substances ECHA informs stakeholders of the progress made and encourages registrants of the substances to start coordinating their actions and to have early interactions with the evaluating Member States. For an overwiew of possibilities of interactions between registrants and evaluating Member States, see the link below.

ECHA's aim is to adopt and publish the final CoRAP update 2015-2017 by the end of March 2015. The final CoRAP update 2015-2017 will indicate the Member State responsible for the evaluation of each substance and the initial reasons of concern together with justification documents. From the publication of the final CoRAP update 2015-2017, the respective Member States have one year to evaluate substances specified for 2015 and, where regarded as necessary, to prepare a draft decision for requesting further information to clarify the suspected risks.